Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ocular fundus chromophores are a diverse group of light-absorbing molecules located in the posterior segment of the eye, primarily within the retina, retinal pigment epithelium (RPE), and choroid. This collective term encompasses endogenous pigments such as rhodopsin and cone opsins, which are essential for phototransduction, as well as melanin, which provides photoprotection and heat dissipation. It also includes macular pigments like lutein and zeaxanthin that filter high-energy blue light, and hemoglobin, which is responsible for oxygen transport in ocular vessels. Additionally, the group includes age-related metabolic byproducts such as lipofuscin (specifically the fluorophore A2E), which can become phototoxic upon accumulation. These chromophores are central to both normal visual function and the pathogenesis of various retinal degenerations, such as age-related macular degeneration (AMD) and Stargardt disease, where the accumulation of toxic byproducts leads to RPE cell death. Therapeutic strategies often involve modulating the visual cycle to reduce the formation of toxic chromophores or utilizing nutritional supplements to bolster protective pigments.
Visual cycle modulation to reduce toxic lipofuscin accumulation; antioxidant supplementation to increase macular pigment density; photodynamic therapy using exogenous chromophores; drug sequestration via melanin binding.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular fundus chromophore.